Related Experiment Video
Updated: Jun 4, 2026
08:40
An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions
Published on: March 14, 2016
Murine interleukin-3: structure, dynamics, and conformational heterogeneity in solution.
Shenggen Yao1, Ian G Young, Raymond S Norton
1The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3052, Australia. syao@wehi.edu.au
Biochemistry
|February 19, 2011
Summary
Researchers determined the structure of murine Interleukin-3 (mIL-3) using NMR, revealing a four-helical bundle fold. Conformational heterogeneity in mIL-3 may explain its interaction with different receptor isoforms.
Area of Science:
- Biochemistry
- Structural Biology
- Immunology
Background:
- Interleukin-3 (IL-3) is a key cytokine regulating immune responses and allergic inflammation.
- The three-dimensional structure of murine IL-3 (mIL-3) has been difficult to determine due to solubility and aggregation issues.
Purpose of the Study:
- To elucidate the solution properties and three-dimensional structure of mIL-3.
- To investigate the structural basis for mIL-3 interactions with its receptor.
Main Methods:
- Nuclear Magnetic Resonance (NMR) spectroscopy was used to study an engineered mIL-3 construct (mIL-3(33-156)).
- Analysis included temperature-dependent chemical shifts and (15)N relaxation dispersion to probe conformational dynamics.
Main Results:
- mIL-3 adopts a four-helical bundle fold, characteristic of short-chain cytokines.
- NMR data revealed significant conformational exchange and local heterogeneity, particularly on one face of the protein.
- Residues critical for receptor binding were found to be relatively rigid, while others exhibited pronounced heterogeneity.
Conclusions:
- The determined structure provides insights into mIL-3's role in allergic inflammation.
- Conformational heterogeneity in mIL-3 may be crucial for differential binding to mIL-3 receptor alpha (mIL-3Rα) isoforms.
- This heterogeneity could facilitate the formation of distinct high-affinity complexes with mIL-3Rα isoforms.
